Urinary miR-210 as a Mediator of Acute T-Cell Mediated Rejection in Renal Allograft Recipients

Mengel, 2007, Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis, Am J Transplant, 7, 512, 10.1111/j.1600-6143.2006.01677.x Ambros, 2004, Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning, Methods Mol Biol, 265, 131 Small, 2011, Pervasive roles of microRNAs in cardiovascular biology, Nature, 469, 336, 10.1038/nature09783 Thum, 2007, MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure, Circulation, 116, 258, 10.1161/CIRCULATIONAHA.107.687947 Lorenzen, 2011, MicroRNAs as mediators and therapeutic targets in chronic kidney disease, Nat Rev Nephrol, 7, 286, 10.1038/nrneph.2011.26 Lodish, 2008, Micromanagement of the immune system by microRNAs, Nat Rev Immunol, 8, 120, 10.1038/nri2252 Harris, 2010, MicroRNAs as immune regulators: Implications for transplantation, Am J Transplant, 10, 713, 10.1111/j.1600-6143.2010.03032.x Gupta, 2010, Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease, Circ Cardiovasc Genet, 3, 484, 10.1161/CIRCGENETICS.110.958363 Hanke, 2010, A robust methodology to study urine microRNA as tumor marker: MicroRNA-126 and microRNA-182 are related to urinary bladder cancer, Urol Oncol, 28, 655, 10.1016/j.urolonc.2009.01.027 Sis, 2009, Banff ‘09 Meeting Report: Antibody mediated graft deterioration and implementation of Banff working groups, Am J Transplant, 10, 464, 10.1111/j.1600-6143.2009.02987.x Fichtlscherer, 2010, Circulating microRNAs in patients with coronary artery disease, Circ Res, 107, 677, 10.1161/CIRCRESAHA.109.215566 Gwinner, 2007, Renal transplant rejection markers, World J Urol, 25, 445, 10.1007/s00345-007-0211-6 Anglicheau, 2009, MicroRNA expression profiles predictive of human renal allograft status, Proc Natl Acad Sci USA, 106, 5330, 10.1073/pnas.0813121106 Fasanaro, 2008, MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosinekinase ligand Ephrin-A3, J Biol Chem, 283, 15878, 10.1074/jbc.M800731200 Neal, 2010, The VHL-dependent regulation of microRNAs in renal cancer, BMC Med, 8, 64, 10.1186/1741-7015-8-64 D’Alessandra, 2010, Circulating microRNAs are new and sensitive biomarkers of myocardial infarction, Eur Heart J, 31, 2765, 10.1093/eurheartj/ehq167 Lorenzen, 2011, MiR-210 predicts survival in critically ill patients with acute kidney injury, Clin J Am Soc Nephrol, 6, 1540, 10.2215/CJN.00430111 Fang, 2010, MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro, Proc Natl Acad Sci USA, 107, 13450, 10.1073/pnas.1002120107 Thum, 2008, MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts, Nature, 456, 980, 10.1038/nature07511 Thum, 2011, Comparison of different miR-21 inhibitor chemistries in a cardiac disease model, J Clin Invest, 121, 461, 10.1172/JCI45938 Wiesen, 2009, Dicer is regulated by cellular stresses and interferons, Mol Immunol, 46, 1222, 10.1016/j.molimm.2008.11.012